ask="5.6000"
ask_size="2500"
average_daily_volume="32147"
bid="3.7500"
bid_size="1600"
book_value="2.1600"
change="-0.1491"
change_from_200_day_moving_average="1.1507"
change_from_50_day_moving_average="0.8491"
change_from_52_week_high="-2.5001"
change_From_52_week_low="1.8599"
change_in_percent="-2.9531%"
close="4.8999"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.8000"
ebitda="-3.22M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="3212000"
high="5.0100"
high_52_weeks="7.4000"
last_trade_date="2/2/2017"
last_trade_price="4.8999"
last_trade_size="863"
last_trade_time="3:21pm"
low="4.7572"
low_52_weeks="3.0400"
market_capitalization="16.55M"
moving_average_200_day="3.7492"
moving_average_50_day="4.0508"
name="BiondVax Pharmaceuticals Ltd."
notes="N/A"
one_year_target_price="15.0000"
open="5.0100"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+30.6936%"
percent_change_from_50_day_moving_average="+20.9625%"
percent_change_from_52_week_high="-33.7851%"
percent_change_from_52_week_low="+61.1809%"
previous_close="5.0490"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.3375"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="3377000"
short_ratio="8.5700"
stock_exchange="NCM"
symbol="BVXV"
volume="6855"
weeks_range_52="3.0400 - 7.4000"
